AA
NARI

AlphaMark Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

AlphaMark Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,377
Closed -$355K – 841
2024
Q2 		$355K Buy
+7,377
New +$327K 0.12% 107

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AlphaMark Advisors's NARI Position: Q3 2024 in Review

AlphaMark Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2024, closing a stake of 7,377 shares — an estimated $355K sold.

AlphaMark Advisors first reported a position in NARI in Q2 2024 and held it in 1 quarter. The position peaked at $355K in Q2 2024. 243 funds tracked by Wall St. Rank hold NARI as of Q3 2024.

  • AlphaMark Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 7,377 Inari Medical, Inc. Common Stock shares in Q3 2024, an estimated $355K.
  • AlphaMark Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • AlphaMark Advisors's Inari Medical, Inc. Common Stock position peaked at $355K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2024.

Based on AlphaMark Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.